Gastric cancerPrognosisMultivariate analysisSurvival rateIndependent prognostic factorTo study the prognostic factors of gastric cancer (GC) patients who were classified with stage III disease according to the newest TNM classification.#This study retrospectively enrolled 279 patients who underwent radical ...
关键词: gastric cancer immunochemotherapy levamisole survival rate DOI: 10.18926/AMO/32404 被引量: 3 年份: 1983 收藏 引用 批量引用 报错 分享 全部来源 免费下载 求助全文 NCBI Europe PMC NCBI ResearchGate pubfacts.com 查看更多 相似文献 参考文献 引证文献...
MethodsOne hundred sixty four patients with stage Ⅲ gastric carcinoma being surgically resected 20-28 days previously were selected and randomly divided into systematic plus hyperthermic intraperitoneal perfusion chemotherapy group and systemic chemotherapy group,3-year/5-year survival rate and side hazard...
Objective response rate OS: Overall survival CI: Confidence interval HR: Hazard ratio References Myall NJ, Das M. Advances in the treatment of Stage III Non-Small Cell Lung Cancer. Clin Chest Med. 2020;41(2):211–22. Article PubMed Google Scholar Godeau D, Petit A, Richard I, ...
Merck’s anti-PD-1 therapy, met its overall survival (OS) endpoint, in combination with chemotherapy as pre-operative (neoadjuvant) treatment and then continuing as a single agent after surgery (adjuvant) for the treatment of patients ...
6 demonstrated that tumor size as a T stage could accurately predict the survival of gastric cancer patients and it was an independent prognostic factor. Kunisaki et al.7 found that tumor size was a reliable prognostic factor of gastric cancer, and thus suggested that it should be included in...
The two main types of lung cancer are non-small cell and small cell. Small cell lung cancer accounts for about 15% of all lung cancers. Patients with small cell lung cancer have a particularly poor pro...
Survival analysis was performed by Kaplan-Meier method and survival rate was obtained by life table method. Multivariate analysis was applied using Cox proportional hazard model. Results Radical surgery was performed in 207 patients; enlargement surgery was done in 3 patients, whereas the palliative ...
The clinical stage III lung cancer accounts for approximately 8–20% of non-small cell lung cancer (NSCLC), with a median of 5-year relative survival rate of around 15.8% [1,2,3]. The National Comprehensive Cancer Network (NCCN) treatment guidelines suggested that concurrent chemoradiotherapy ...
To capture unique phosphosites in HER2-positive gastric cancer, we overlaid the phosphoproteomic data from the pre-treatment HER2-positive and HER2-negative T groups with phosphosites in the ErbB signaling pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Fig. 3, Table S5...